Literature DB >> 3452344

Waist-to-hip ratio as an index of risk for hyperglycemia among hypertensive patients.

L M Gerber1, S Madhavan, M H Alderman.   

Abstract

Participants in a systematic antihypertensive care program were examined to determine whether the site of fat predominance--measured by the waist-to-hip ratio--is related to hyperglycemia in patients taking diuretics. Among 1,044 hypertensive patients meeting a set of selection criteria, 22 men who developed hyperglycemia during a mean treatment period of 25.6 months were identified and individually matched for age, race, body mass index, and duration of diuretic treatment to a comparable group of hypertensive patients who remained normoglycemic. The mean waist-to-hip ratio was higher among the hyperglycemic men, although this difference did not reach conventional levels of statistical significance. However, a significantly greater proportion of the hyperglycemic men than those who were normoglycemic fell into a higher ratio category when waist-to-hip ratios were classified according to whether they were less than or greater than or equal to 0.90. When the ratios were examined in relation to body mass index, the greatest difference between the two groups was observed in the leanest group. This study suggests that the waist-to-hip ratio, in conjunction with total body fatness, may be an important tool for distinguishing persons with hypertension who may develop hyperglycemia when treated with diuretics.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3452344

Source DB:  PubMed          Journal:  Am J Prev Med        ISSN: 0749-3797            Impact factor:   5.043


  2 in total

1.  Association of waist to hip ratio and family history with the prevalence of NIDDM among 25,272 adult, white females.

Authors:  R D Morris; A A Rimm
Journal:  Am J Public Health       Date:  1991-04       Impact factor: 9.308

2.  Effect of conjugated linoleic acid and vitamin E on glycemic control, body composition, and inflammatory markers in overweight type2 diabetics.

Authors:  Zhaleh Shadman; Forough Azam Taleban; Navid Saadat; Mehdi Hedayati
Journal:  J Diabetes Metab Disord       Date:  2013-07-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.